Diet & Nutrition
Vitamin B12 reduces ribavirin-induced genotoxicity in lymphocytes
Published in Health and Medicine Week, October 2nd, 2006
According to a study from Serbia, "Ribavirin, an N-glycosyl nucleoside (1,6-D-ribofuranosyl-1,2,4-triazole-3 carboxamide), is a synthetic purine nucleoside analogue with a broad spectrum of antiviral activity, however, its high toxicity poses a major disadvantage of its use as a therapeutic. Various studies have shown that vitamin B12 plays a significant role in maintaining the stability of the human genome."
"We therefore investigated the potential beneficial effect of vitamin B12 in reducing ribavirin-induced...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
More Articles from Health and Medicine Week
- Antibacterial Agents
Compounds in cranberry juice show promise as alternatives to antibiotics - Avian Influenza
Live H5N1 bird flu virus vaccines show protection in animal studies - Cancer Research
Regular exercise significantly reduces markers of increased colon-cancer risk in men - Diet & Nutrition
Lower body satisfaction predicts behaviors that may place youth at risk for weight gain - AAT Deficiency
Extensive post-license data reaffirm clinical safety profile of Prolastin - Acoustic Research
Technique for measuring indoor acoustics may lead to building design changes - More from this issue of Health and Medicine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
